These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29140649)

  • 1. The Extent of Harm to the Victim as an Alternative Aggravating Factor for the Conviction of Felony Fraud in the Context of Food-Safety Violations.
    Su YC
    Food Drug Law J; 2016; 71(4):658-72. PubMed ID: 29140649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
    Murdey J
    Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither aider nor abettor be: attorneys become prosecutorial targets for federal healthcare crimes.
    Schmidt MM
    J Health Law; 1999; 32(2):251-67. PubMed ID: 10623096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care fraud: a growing problem.
    Lovitky JA
    Nurs Manage; 1997 Nov; 28(11):42-5. PubMed ID: 9385156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consultant relationships may pose liability risk.
    Imperato GL
    Healthc Financ Manage; 2003 Jan; 57(1):72-5. PubMed ID: 12553236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stacked penalties raise stakes in fraud and abuse prosecutions.
    Fabrikant R; Wester J
    Healthc Financ Manage; 2000 Sep; 54(9):46-50. PubMed ID: 11066388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The civil liability for damages of the criminally insane.
    Melamed Y; Ganot N; Mester R; Bleich A
    Isr J Psychiatry Relat Sci; 2008; 45(4):285-90. PubMed ID: 19439834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing Food Fraud including translation and interpretation to Russian, Korean, and Chinese languages.
    Spink J; Moyer DC; Park H; Wu Y; Fersht V; Shao B; Hong M; Paek SY; Edelev D
    Food Chem; 2015 Dec; 189():102-7. PubMed ID: 26190607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic credentialing and the fraud and abuse caveat.
    Benesch K
    Med Staff Couns; 1992; 6(4):27-35. PubMed ID: 10122126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corporate compliance: implications for trustees.
    Commins K
    Mich Health Hosp; 1998; 34(1):14. PubMed ID: 10176194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the public health threat of food fraud.
    Spink J; Moyer DC
    J Food Sci; 2011; 76(9):R157-63. PubMed ID: 22416717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The False Claims Act and clinical laboratories.
    Vogel RL
    Clin Lab Manage Rev; 1993; 7(5):442-5. PubMed ID: 10128849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A warning to physicians: changing landscape of the corporate-provider relationship.
    Shah UK; Smith GM; Ziv BE; Reilly JS
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):697-9. PubMed ID: 18503838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fraud in scientific research: the prosecutor's approach.
    Willcox BL
    Account Res; 1992; 2(2):139-51. PubMed ID: 16144093
    [No Abstract]   [Full Text] [Related]  

  • 16. Solicitation of new safe harbors and special fraud alerts--OIG, HHS. Notice of intent to develop regulations.
    Fed Regist; 1998 Dec; 63(237):68223-4. PubMed ID: 10338886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is a board's liability for not adopting a compliance program?
    Robinson F; Pauzé CC
    Healthc Financ Manage; 1997 Sep; 51(9):64-6. PubMed ID: 10170320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kickbacks, self-referrals, and false claims: the hazy boundaries of health-care fraud.
    Krause JH
    Chest; 2013 Sep; 144(3):1045-1050. PubMed ID: 24008955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal compliance systems are the best defense against fraud.
    Serbaroli FJ
    Healthc Financ Manage; 1994 Nov; 48(11):60, 62, 64-5. PubMed ID: 10146097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OIG increases amount, scope of civil money penalties for fraud.
    Natl Rep Subacute Care; 2000 May; 8(10):4-6. PubMed ID: 11066242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.